Effect of Symbicort on Sleep Quality in Patients With Emphysema
| Status: | Completed |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | March 2011 |
| End Date: | August 2014 |
| Contact: | Sylvia Johnson, RN |
| Email: | breathe@temple.edu |
| Phone: | 215-707-1359 |
This study will look at the effects of the drug Symbicort on sleep quality. Symbicort is an
inhaled medication that contains 2 drugs. One is a medication that opens up the airways
(formoterol). The other is a steroid to decrease airway inflammation (budesonide).
Symbicort is not an experimental medication. It is approved by the Food and Drug
Administration for use in patients with emphysema. Patients with severe emphysema commonly
sleep poorly. The cause of poor sleep in these patients is unknown. Symbicort may improve
sleep quality by opening the airways and reducing lung inflammation. It is not known for
sure if these effects actually improve sleep and quality of life. It is hoped that this
study will answer this question.
Inclusion Criteria:
- Moderate to severe emphysema (GOLD stages 2 and 3)
Exclusion Criteria:
- Use of supplemental oxygen,
- A recent COPD exacerbation within the past 4 weeks.
- A previous diagnosis of obstructive sleep apnea
- A known urinary outflow obstruction,
- Glaucoma
- History of an allergic reaction to one of the study medications.
We found this trial at
1
site
Click here to add this to my saved trials
